These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8525810)

  • 1. A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier.
    Uchino M; Uyama E; Kawano H; Hokamaki J; Kugiyama K; Murakami Y; Yasue H; Ando M
    Acta Neuropathol; 1995; 90(3):334-8. PubMed ID: 8525810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry cardiomyopathy in the female confirmed by endomyocardial biopsy.
    Broadbent JC; Edwards WD; Gordon H; Hartzler GO; Krawisz JE
    Mayo Clin Proc; 1981 Oct; 56(10):623-8. PubMed ID: 6268901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and electron microscopy findings in myocardium of treated Fabry disease.
    Owens CL; Russell SD; Halushka MK
    Hum Pathol; 2006 Jun; 37(6):764-8. PubMed ID: 16733219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study.
    Chimenti C; Padua L; Pazzaglia C; Morgante E; Centurion C; Antuzzi D; Russo MA; Frustaci A
    Hum Pathol; 2012 Sep; 43(9):1444-52. PubMed ID: 22406371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vasculature in Fabry's disease.
    Smith P; Heath D; Rodgers B; Helliwell T
    Histopathology; 1991 Dec; 19(6):567-9. PubMed ID: 1786942
    [No Abstract]   [Full Text] [Related]  

  • 6. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
    Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
    Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histochemical and electron microscopic study of skeletal muscle in an adult case of Chédiak-Higashi syndrome.
    Uchino M; Uyama E; Hirano T; Nakamura T; Fukushima T; Ando M
    Acta Neuropathol; 1993; 86(5):521-4. PubMed ID: 8310803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
    Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
    J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease.
    Roos JM; Aubry MC; Edwards WD
    Cardiovasc Pathol; 2002; 11(5):277-83. PubMed ID: 12361838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmortem diagnosis of Fabry disease with acromegaly and a unique vasculopathy.
    Takao M; Mori T; Orikasa H; Oh H; Suzuki K; Koto A; Yamazaki K
    Virchows Arch; 2007 Sep; 451(3):721-7. PubMed ID: 17624552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy.
    Abraham SC; DeNofrio D; Loh E; Minda JM; Tomaszewski JE; Pietra GG; Reynolds C
    Hum Pathol; 1998 Aug; 29(8):876-82. PubMed ID: 9712432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
    Veinot JP
    Circulation; 2002 Oct; 106(15):e73; author reply e73. PubMed ID: 12370238
    [No Abstract]   [Full Text] [Related]  

  • 13. Fabry disease with few clinical signs and symptoms.
    Asahi K; Katoh T; Watanabe K; Watanabe T
    Intern Med; 2002 Nov; 41(11):983-5. PubMed ID: 12487173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.
    Wang RY; Abe JT; Cohen AH; Wilcox WR
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S369-74. PubMed ID: 18937048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease.
    Apelland T; Gude E; Strøm EH; Gullestad L; Eiklid KL; Månsson JE; Reinholt FP; Houge G; Dahl CP; Almaas VM; Heiberg A
    Heart; 2014 Nov; 100(22):1793-8. PubMed ID: 25031264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ultrastructural study in a case of Fabry disease.
    Palungwachira P; Yaguchi H
    J Med Assoc Thai; 2002 Jul; 85(7):842-9. PubMed ID: 12296419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
    Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine-induced lipidosis mimicking Fabry disease.
    Albay D; Adler SG; Philipose J; Calescibetta CC; Romansky SG; Cohen AH
    Mod Pathol; 2005 May; 18(5):733-8. PubMed ID: 15605079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic body myopathy with hypertrophic cardiomyopathy.
    Sekijima Y; Ikeda S; Katai S; Matsuda M; Hashimoto T; Haruta S; Owa M; Sakai T; Takeda S; Yanagisawa N
    Intern Med; 1995 Mar; 34(3):166-70. PubMed ID: 7787321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal glycogen storage disease with normal acid maltase with early fatal outcome.
    Morisawa Y; Fujieda M; Murakami N; Naruse K; Okada T; Morita H; Sawada K; Miyazaki J; Kurashige T; Nonaka I
    J Neurol Sci; 1998 Oct; 160(2):175-9. PubMed ID: 9849802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.